Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 10/20 | 0.62 |
| ▸ | FAAH | O00519 | 4/20 | 0.62 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | HPN | P05981 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8530013 | 0.85 | MGLL (0.67) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL522308 | 0.84 | NSD2 (0.67) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL10515423 | 0.84 | PARP1 (0.65) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL32670837 | 0.84 | NSD2 (0.67) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL11023896 | 0.84 | MGLL (0.64) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL29510746 | 0.84 | PARP1 (0.65) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL24529797 | 0.82 | MGLL (0.62) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL4594492 | 0.82 | MGLL (0.62) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| Hydrochloric Acid SCHEMBL4956408 | 0.82 | NSD2 (0.65) | MGLLFAAHHSP90AA1MAPTMEN1 | |
| SCHEMBL29510515 | 0.82 | MGLL (0.62) | MGLLFAAHHSP90AA1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117987061-A | Photo-curing adhesive for bonding flexible printed circuit board and preparation method thereof | 青岛德聚胶接技术有限公司 | 2024-05-07 | — | — | CN | claimed |
| JP-62252455-A | — | — | None | — | — | JP | disclosed |
| CN-117987061-B | Photo-curing adhesive for bonding flexible printed circuit board and preparation method thereof | 青岛德聚胶接技术有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-117987061-A | Photo-curing adhesive for bonding flexible printed circuit board and preparation method thereof | 青岛德聚胶接技术有限公司 | 2024-05-07 | — | — | CN | disclosed |
| US-20090162290-A1 | METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF | THERAPHARM GMBH | 2009-06-25 | — | — | US | disclosed |
| EP-1942949-A1 | METHOD FOR THE SYNTHESIS OF PENTAPENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIO-CONJUGATES PREPARATION BY A COVALENT BINDING OF THEREOF | Therapharm GmbH (CH) | 2008-07-16 | — | — | EP | disclosed |
| US-7344699-B2 | Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2008-03-18 | — | — | US | disclosed |
| WO-2007028639-A1 | METHOD FOR THE SYNTHESIS OF PENTAPENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIO-CONJUGATES PREPARATION BY A COVALENT BINDING OF THEREOF | THERAPHARM GMBH (CH) | 2007-03-15 | — | — | WO | disclosed |
| US-20060057063-A1 | Medicaments | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2006-03-16 | — | — | US | disclosed |
| EP-1526866-A2 | DRUG CONJUGATE COMPRISING AN ERYTHROPOIETIN RECEPTOR LIGAND AND AN ANTICANCER AGENT | The Queen's University of Belfast (GB) | 2005-05-04 | — | — | EP | disclosed |
| WO-2003097106-A2 | DRUG CONJUGATE COMPRISING AN ERYTHROPOIETIN RECEPTOR LIGAND AND AN ANTICANCER AGENT | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2003-11-27 | — | — | WO | disclosed |
| US-6329531-B1 | FOR THERAPY OF ALZHEIMER'S DISEASE | SCHERING AG (DE) | 2001-12-11 | — | — | US | disclosed |
| US-4851494-A | MOLDING, COATING | CIBA-GEIGY CORPORATION (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0300970-A1 | Curable polyether amides | CIBA-GEIGY AG (CH) | 1989-01-25 | — | — | EP | disclosed |
| JP-S62252455-A | POLYAMIDE BISMALEIMIDE RESIN COMPOSITION | YOBEA RULON KOGYO KK | 1987-11-04 | — | — | JP | disclosed |
| US-4629689-A | Binding assay with amplified read-out and gas-phase detection | ALLIED CORPORATION (US) | 1986-12-16 | — | — | US | disclosed |
| EP-0173055-A2 | Binding assay with amplified read-out and gas-phase detection | ALLIED CORPORATION (US) | 1986-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162290-A1 | METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF | C5, C3AR1, SPR | MGLL 4807/4885FAAH 4005/4885HSP90AA1 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.